{"version":"1.0","provider_name":"South Africa Journal","provider_url":"https:\/\/southafricajournal.com","author_name":"sjadmin","author_url":"https:\/\/southafricajournal.com\/author\/sjadmin-s\/","title":"Grifols further expands its activity in Africa with agreement to set up an intravenous solutions manufacturing plant in Nigeria - South Africa Journal","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"IdXOf0tz4J\"><a href=\"https:\/\/southafricajournal.com\/grifols-further-expands-its-activity-in-africa-with-agreement-to-set-up-an-intravenous-solutions-manufacturing-plant-in-nigeria\/\">Grifols further expands its activity in Africa with agreement to set up an intravenous solutions manufacturing plant in Nigeria<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/southafricajournal.com\/grifols-further-expands-its-activity-in-africa-with-agreement-to-set-up-an-intravenous-solutions-manufacturing-plant-in-nigeria\/embed\/#?secret=IdXOf0tz4J\" width=\"600\" height=\"338\" title=\"&#8220;Grifols further expands its activity in Africa with agreement to set up an intravenous solutions manufacturing plant in Nigeria&#8221; &#8212; South Africa Journal\" data-secret=\"IdXOf0tz4J\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"\u2013 To be constructed by Grifols Engineering, a global standard-bearer in the development and building of advanced production facilities for the healthcare and biotechnology industries \u2013 The plant will be operational in 2024 and will produce 5.5 million intravenous solutions (IV) bags yearly for the plant\u2019s owner, Dozie and Dozie\u2019s Pharma Nig Ltd., a leading [\u2026]","thumbnail_url":"https:\/\/ci6.googleusercontent.com\/proxy\/EcMu26aDRJqvqP1Y6bhEa-e83OqLbQH44T5OG11bfhZ3cnXNswt7ru2qwNA96tuLMSnKADMhvWZrEWv2giHyEgMVR8sYr5UH4dzT=s0-d-e1-ft#https:\/\/mma.prnewswire.com\/media\/463444\/Grifols_Logo.jpg"}